Abstract
Peripheral arterial disease (PAD) is a progressive disease most often due to atherosclerosis and characterized by obstruction of arterial blood flow in the lower limbs. The defining symptom of PAD, intermittent claudication, is evident in only a minority of patients, leading to frequent underdiagnosis. Patients with PAD are more likely to suffer from polyvascular disease than patients with other cardiovascular conditions and have an increased risk of cardiovascular death and ischemic events. This review considers current PAD awareness and treatment, including important findings from the REduction of Atherothrombosis for Continued Health (REACH) and PAD Awareness, Risk and Treatment: New Resources for Survival (PARTNERS) registries. Information on simple diagnostic tools to aid early PAD detection and therapeutic options for global atherosclerosis risk factor management are also presented.
Keywords: Peripheral arterial disease, cardiovascular disease, atherosclerosis, secondary prevention, ankle-brachial index
Current Vascular Pharmacology
Title: The Importance of Early Diagnosis and Treatment in Peripheral Arterial Disease: Insights from the PARTNERS and REACH Registries
Volume: 8 Issue: 3
Author(s): Debabrata Mukherjee and Kim Eagle
Affiliation:
Keywords: Peripheral arterial disease, cardiovascular disease, atherosclerosis, secondary prevention, ankle-brachial index
Abstract: Peripheral arterial disease (PAD) is a progressive disease most often due to atherosclerosis and characterized by obstruction of arterial blood flow in the lower limbs. The defining symptom of PAD, intermittent claudication, is evident in only a minority of patients, leading to frequent underdiagnosis. Patients with PAD are more likely to suffer from polyvascular disease than patients with other cardiovascular conditions and have an increased risk of cardiovascular death and ischemic events. This review considers current PAD awareness and treatment, including important findings from the REduction of Atherothrombosis for Continued Health (REACH) and PAD Awareness, Risk and Treatment: New Resources for Survival (PARTNERS) registries. Information on simple diagnostic tools to aid early PAD detection and therapeutic options for global atherosclerosis risk factor management are also presented.
Export Options
About this article
Cite this article as:
Mukherjee Debabrata and Eagle Kim, The Importance of Early Diagnosis and Treatment in Peripheral Arterial Disease: Insights from the PARTNERS and REACH Registries, Current Vascular Pharmacology 2010; 8 (3) . https://dx.doi.org/10.2174/157016110791112304
DOI https://dx.doi.org/10.2174/157016110791112304 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Targets for Heart Failure: Beyond Beta-Adrenergic and Renin-Angiotensin System Blockade
Recent Patents on Cardiovascular Drug Discovery Epigenetic Mechanisms in Alzheimer's Disease
Current Medicinal Chemistry Antineoplastic Chemotherapy Induced QTc Prolongation
Current Drug Safety Pathophysiology of Necrotizing Enterocolitis: An Update
Current Pediatric Reviews Erythropoiesis Stimulating Agents and Anaemia of End-Stage Renal Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Nitric Oxide as a Marker for Levo-Thyroxine Therapy in Subclinical Hypothyroid Patients
Current Vascular Pharmacology microRNAs in Cancer: Lessons from Melanoma
Current Pharmaceutical Design Association of Admission Leukocyte Count with Clinical Outcomes in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator
Current Neurovascular Research New Achievements in Bioinformatics Prediction of Post Translational Modification of Proteins
Current Topics in Medicinal Chemistry Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients
Current Vascular Pharmacology The Progress Towards the Development of DHQO Derivatives and Related Analogues with Inotropic Effects
Mini-Reviews in Medicinal Chemistry Statins in Stroke Prevention: Present and Future
Current Pharmaceutical Design Controversies on HDL: Should it be a Target Biomarker in Patients with Lipid Disorders?
Current Vascular Pharmacology AMP-Activated Protein Kinase: Structure and Regulation
Current Protein & Peptide Science Pro-Angiogenic Effect of Endomyocardial Biopsy-Derived Cells for Cardiac Regeneration
Current Tissue Engineering (Discontinued) The Assessment of Platelet Activation in Antiplatelet Drug Development
Current Medicinal Chemistry Drugs Designed to Improve Endothelial Function: Effects on Erectile Dysfunction
Current Pharmaceutical Design IP6 in Cancer Therapy: Past, Present and Future
Current Cancer Therapy Reviews Serum Vitamin D Concentration and Potential Risk Factors for its Deficiency in HIV Positive Individuals
Current HIV Research Vascular Patency: A Biomarker and Clinical Target Quantified with High Resolution MRI and Novel Cellular Pathways
Current Neurovascular Research